Eli Lilly and Co
LLY
Company Profile
Business description
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Contact
Lilly Corporate Center
IndianapolisIN46285
USAT: +1 317 276-2000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
43,000
Stocks News & Analysis
stocks
Ask the analyst: Can this big Covid loser scale its former heights?
Corporate Travel Management saw its profits fall through the floor during the pandemic. Our analyst Brian Han answers a reader question on what might be next.
stocks
The fight for Insignia continues
Numerous acquisition proposals vindicate Insignia's improved earnings momentum.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,660.40 | 31.30 | 0.36% |
| CAC 40 | 7,922.68 | 4.94 | -0.06% |
| DAX 40 | 21,324.14 | 70.79 | -0.33% |
| Dow JONES (US) | 44,376.67 | 47.58 | -0.11% |
| FTSE 100 | 8,506.97 | 4.62 | 0.05% |
| HKSE | 20,197.77 | 131.58 | 0.66% |
| NASDAQ | 19,466.49 | 487.81 | -2.44% |
| Nikkei 225 | 39,565.80 | 366.18 | -0.92% |
| NZX 50 Index | 12,999.72 | 24.98 | -0.19% |
| S&P 500 | 6,008.38 | 92.86 | -1.52% |
| S&P/ASX 200 | 8,408.90 | 30.20 | 0.36% |
| SSE Composite Index | 3,250.60 | 2.03 | -0.06% |